In the 1980s and 90s, pharmaceutical companies began to market opioid painkillers aggressively, actively downplaying their addictive potential to both the medical community and the public.
En los años 80 y 90, empresas farmacéuticas comercializaron analgésicos opioides contundentemente, restándole importancia a su potencial adictivo tanto a la comunidad médica como al público.